+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mycoplasma Testing Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments and Services), By Technology, By Application, By End User, By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • January 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5935316
The Global Mycoplasma Testing Market size is expected to reach $1.9 billion by 2030, rising at a market growth of 11.5% CAGR during the forecast period.

The increasing awareness of the impact of mycoplasma contamination on cell culture research outcomes drives the growth of this testing in academic settings. Academic research institutes heavily rely on cell cultures for various studies, from basic cell biology to disease modeling and drug discovery. Consequently, the academic research institutes segment would acquire nearly 15 % of the total market share by 2030. Researchers prioritize implementing this testing to maintain the reliability of their experiments. Developing tissue engineering and three-dimensional (3D) cell culture models in academic research requires stringent quality control measures, including this testing. As researchers explore advanced cell culture techniques, the demand for these testing solutions that accommodate diverse models and experimental setups increases.



Advances in these testing methods, including rapid and high-throughput technology development, contribute to the market's growth. Technological innovations make testing more efficient, sensitive, and cost-effective, driving adoption across various industries. Mass spectrometry-based approaches, like matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), are gaining traction in mycoplasma identification. These techniques provide high-resolution and accurate identification of microbial species, including mycoplasma. Hence, the market is expanding significantly due to the technological advancements in testing methods. Additionally, the growth of the biopharmaceutical and biotechnology industries, characterized by the increasing production of therapeutic proteins, monoclonal antibodies, and other biologics, fuels the demand for this testing. The increasing production of biosimilars and biological products like approved biopharmaceuticals contributes to the demand for this testing. Thus, because of the rising biopharmaceutical and biotechnology industries, the market is anticipated to increase significantly.

Moreover, the COVID-19 pandemic intensified the global focus on vaccine development and biopharmaceutical production. With accelerated efforts to produce vaccines and therapeutic biologics, the demand for these testing solutions increased to ensure the quality and safety of these products. The urgency to develop and produce vaccines and therapeutics during the pandemic led to increased regulatory scrutiny. Regulatory agencies emphasized the importance of stringent quality control measures, including this testing, to ensure the safety and efficacy of emerging treatments. Thus, the COVID-19 pandemic had a moderate effect on the market.

However, Variations in results may result from the absence of standardized testing procedures among laboratories and regions. Achieving a universal standard for this testing is challenging due to the diversity of testing techniques and technologies used in different settings. Standardization may lead to complacency in continuously improving these testing methodologies. The assumption that a standardized method is universally applicable may discourage efforts to enhance testing technologies and protocols further. Hence, standardization of testing methods is a significant challenge that hampers the growth of market.

By Technology Analysis

Based on technology, the market is classified into PCR, ELISA, microbial culture techniques, and enzymatic methods. The microbial culture techniques segment acquired a substantial revenue share in the market in 2022. Culturing mycoplasma isolates allows species identification, allowing laboratories to determine the specific types of mycoplasma present. This information can be valuable for understanding the nature of contamination and tailoring appropriate responses. Microbial culture techniques enable the testing of viable mycoplasma organisms, providing information on their ability to replicate and cause harm to cell cultures or biopharmaceutical products. This aspect is crucial for understanding the potential impact of contamination on production processes.

By Application Analysis

On the basis of application, the market is divided into cell line testing, virus testing, end of production cells testing, and others. The virus testing segment garnered a significant revenue share in the market in 2022. Virus testing, alongside this testing, helps prevent cross-contamination in shared laboratory spaces and manufacturing facilities. The risk of cross-contamination between different cell lines or production batches is a concern that both types of testing address to maintain the integrity of biological products. Thorough virus and this testing helps to build public trust in the safety and efficacy of pharmaceutical and biopharmaceutical products. Ensuring that these products are free from harmful contaminants is paramount for the safety of patients and consumers.



By End User Analysis

By end user, the market is segmented into academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies, and others. The contract research organizations segment recorded a remarkable revenue share in the market in 2022. Contract research organizations (CROs) conduct preclinical and clinical studies for pharmaceutical and biotechnology companies. In these studies, this testing is essential to ensure the integrity of cell cultures and prevent contamination that can affect the reliability of study outcomes. CROs are early adopters of technological advancements in these testing methods. Their commitment to staying at the forefront of testing technologies drives the adoption of innovative and efficient mycoplasma detection methods.

By Product & Service Analysis

By product & services, the market is categorized into instruments, kits & reagents, and services. The instruments segment covered a considerable revenue share in the market in 2022. Polymerase chain reaction (PCR) machines are widely used in this testing for amplifying and detecting specific DNA sequences. PCR-based assays are highly sensitive and specific, allowing for the rapid and accurate identification of mycoplasma DNA in samples. Microscopes, including fluorescent microscopy systems, are used to observe mycoplasma contamination in cell cultures directly. Fluorescent dyes are applied to label mycoplasma cells, making them visible under a microscope. This method allows for quick and direct visualization of contamination.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The biopharmaceutical industry in North America strongly emphasizes maintaining high manufacturing standards. Academic and research institutions in North America are actively involved in cell culture research, ranging from basic cell biology to advanced applications in biotechnology. The region is an early adopter of advanced testing technologies, including rapid and high-throughput methods for mycoplasma detection.

List of Key Companies Profiled

  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific SE
  • Lonza Group Ltd.
  • Bio-Rad Laboratories, Inc.
  • InvivoGen SAS
  • Asahi Kasei Corporation
  • F.Hoffmann-La Roche Ltd.
  • Norgen Biotek Corp.
  • PromoCell GmbH

Market Report Segmentation

By Product & Service
  • Kits & Reagents
  • Instruments
  • Services
By Technology
  • PCR
  • ELISA
  • Microbial Culture Techniques
  • Enzymatic Methods
By Application
  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others
By End User
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Cell Banks
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Mycoplasma Testing Market, by Product & Service
1.4.2 Global Mycoplasma Testing Market, by Technology
1.4.3 Global Mycoplasma Testing Market, by Application
1.4.4 Global Mycoplasma Testing Market, by End User
1.4.5 Global Mycoplasma Testing Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Global Mycoplasma Testing Market by Product & Service
4.1 Global Kits & Reagents Market by Region
4.2 Global Instruments Market by Region
4.3 Global Services Market by Region
Chapter 5. Global Mycoplasma Testing Market by Technology
5.1 Global PCR Market by Region
5.2 Global ELISA Market by Region
5.3 Global Microbial Culture Techniques Market by Region
5.4 Global Enzymatic Methods Market by Region
Chapter 6. Global Mycoplasma Testing Market by Application
6.1 Global Cell Line Testing Market by Region
6.2 Global Virus Testing Market by Region
6.3 Global End of Production Cells Testing Market by Region
6.4 Global Others Market by Region
Chapter 7. Global Mycoplasma Testing Market by End User
7.1 Global Pharmaceutical & Biotechnology Companies Market by Region
7.2 Global Contract Research Organizations Market by Region
7.3 Global Academic Research Institutes Market by Region
7.4 Global Cell Banks Market by Region
7.5 Global Others Market by Region
Chapter 8. Global Mycoplasma Testing Market by Region
8.1 North America Mycoplasma Testing Market
8.1.1 North America Mycoplasma Testing Market by Product & Service
8.1.1.1 North America Kits & Reagents Market by Country
8.1.1.2 North America Instruments Market by Country
8.1.1.3 North America Services Market by Country
8.1.2 North America Mycoplasma Testing Market by Technology
8.1.2.1 North America PCR Market by Country
8.1.2.2 North America ELISA Market by Country
8.1.2.3 North America Microbial Culture Techniques Market by Country
8.1.2.4 North America Enzymatic Methods Market by Country
8.1.3 North America Mycoplasma Testing Market by Application
8.1.3.1 North America Cell Line Testing Market by Country
8.1.3.2 North America Virus Testing Market by Country
8.1.3.3 North America End of Production Cells Testing Market by Country
8.1.3.4 North America Others Market by Country
8.1.4 North America Mycoplasma Testing Market by End User
8.1.4.1 North America Pharmaceutical & Biotechnology Companies Market by Country
8.1.4.2 North America Contract Research Organizations Market by Country
8.1.4.3 North America Academic Research Institutes Market by Country
8.1.4.4 North America Cell Banks Market by Country
8.1.4.5 North America Others Market by Country
8.1.5 North America Mycoplasma Testing Market by Country
8.1.5.1 US Mycoplasma Testing Market
8.1.5.1.1 US Mycoplasma Testing Market by Product & Service
8.1.5.1.2 US Mycoplasma Testing Market by Technology
8.1.5.1.3 US Mycoplasma Testing Market by Application
8.1.5.1.4 US Mycoplasma Testing Market by End User
8.1.5.2 Canada Mycoplasma Testing Market
8.1.5.2.1 Canada Mycoplasma Testing Market by Product & Service
8.1.5.2.2 Canada Mycoplasma Testing Market by Technology
8.1.5.2.3 Canada Mycoplasma Testing Market by Application
8.1.5.2.4 Canada Mycoplasma Testing Market by End User
8.1.5.3 Mexico Mycoplasma Testing Market
8.1.5.3.1 Mexico Mycoplasma Testing Market by Product & Service
8.1.5.3.2 Mexico Mycoplasma Testing Market by Technology
8.1.5.3.3 Mexico Mycoplasma Testing Market by Application
8.1.5.3.4 Mexico Mycoplasma Testing Market by End User
8.1.5.4 Rest of North America Mycoplasma Testing Market
8.1.5.4.1 Rest of North America Mycoplasma Testing Market by Product & Service
8.1.5.4.2 Rest of North America Mycoplasma Testing Market by Technology
8.1.5.4.3 Rest of North America Mycoplasma Testing Market by Application
8.1.5.4.4 Rest of North America Mycoplasma Testing Market by End User
8.2 Europe Mycoplasma Testing Market
8.2.1 Europe Mycoplasma Testing Market by Product & Service
8.2.1.1 Europe Kits & Reagents Market by Country
8.2.1.2 Europe Instruments Market by Country
8.2.1.3 Europe Services Market by Country
8.2.2 Europe Mycoplasma Testing Market by Technology
8.2.2.1 Europe PCR Market by Country
8.2.2.2 Europe ELISA Market by Country
8.2.2.3 Europe Microbial Culture Techniques Market by Country
8.2.2.4 Europe Enzymatic Methods Market by Country
8.2.3 Europe Mycoplasma Testing Market by Application
8.2.3.1 Europe Cell Line Testing Market by Country
8.2.3.2 Europe Virus Testing Market by Country
8.2.3.3 Europe End of Production Cells Testing Market by Country
8.2.3.4 Europe Others Market by Country
8.2.4 Europe Mycoplasma Testing Market by End User
8.2.4.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
8.2.4.2 Europe Contract Research Organizations Market by Country
8.2.4.3 Europe Academic Research Institutes Market by Country
8.2.4.4 Europe Cell Banks Market by Country
8.2.4.5 Europe Others Market by Country
8.2.5 Europe Mycoplasma Testing Market by Country
8.2.5.1 Germany Mycoplasma Testing Market
8.2.5.1.1 Germany Mycoplasma Testing Market by Product & Service
8.2.5.1.2 Germany Mycoplasma Testing Market by Technology
8.2.5.1.3 Germany Mycoplasma Testing Market by Application
8.2.5.1.4 Germany Mycoplasma Testing Market by End User
8.2.5.2 UK Mycoplasma Testing Market
8.2.5.2.1 UK Mycoplasma Testing Market by Product & Service
8.2.5.2.2 UK Mycoplasma Testing Market by Technology
8.2.5.2.3 UK Mycoplasma Testing Market by Application
8.2.5.2.4 UK Mycoplasma Testing Market by End User
8.2.5.3 France Mycoplasma Testing Market
8.2.5.3.1 France Mycoplasma Testing Market by Product & Service
8.2.5.3.2 France Mycoplasma Testing Market by Technology
8.2.5.3.3 France Mycoplasma Testing Market by Application
8.2.5.3.4 France Mycoplasma Testing Market by End User
8.2.5.4 Russia Mycoplasma Testing Market
8.2.5.4.1 Russia Mycoplasma Testing Market by Product & Service
8.2.5.4.2 Russia Mycoplasma Testing Market by Technology
8.2.5.4.3 Russia Mycoplasma Testing Market by Application
8.2.5.4.4 Russia Mycoplasma Testing Market by End User
8.2.5.5 Spain Mycoplasma Testing Market
8.2.5.5.1 Spain Mycoplasma Testing Market by Product & Service
8.2.5.5.2 Spain Mycoplasma Testing Market by Technology
8.2.5.5.3 Spain Mycoplasma Testing Market by Application
8.2.5.5.4 Spain Mycoplasma Testing Market by End User
8.2.5.6 Italy Mycoplasma Testing Market
8.2.5.6.1 Italy Mycoplasma Testing Market by Product & Service
8.2.5.6.2 Italy Mycoplasma Testing Market by Technology
8.2.5.6.3 Italy Mycoplasma Testing Market by Application
8.2.5.6.4 Italy Mycoplasma Testing Market by End User
8.2.5.7 Rest of Europe Mycoplasma Testing Market
8.2.5.7.1 Rest of Europe Mycoplasma Testing Market by Product & Service
8.2.5.7.2 Rest of Europe Mycoplasma Testing Market by Technology
8.2.5.7.3 Rest of Europe Mycoplasma Testing Market by Application
8.2.5.7.4 Rest of Europe Mycoplasma Testing Market by End User
8.3 Asia Pacific Mycoplasma Testing Market
8.3.1 Asia Pacific Mycoplasma Testing Market by Product & Service
8.3.1.1 Asia Pacific Kits & Reagents Market by Country
8.3.1.2 Asia Pacific Instruments Market by Country
8.3.1.3 Asia Pacific Services Market by Country
8.3.2 Asia Pacific Mycoplasma Testing Market by Technology
8.3.2.1 Asia Pacific PCR Market by Country
8.3.2.2 Asia Pacific ELISA Market by Country
8.3.2.3 Asia Pacific Microbial Culture Techniques Market by Country
8.3.2.4 Asia Pacific Enzymatic Methods Market by Country
8.3.3 Asia Pacific Mycoplasma Testing Market by Application
8.3.3.1 Asia Pacific Cell Line Testing Market by Country
8.3.3.2 Asia Pacific Virus Testing Market by Country
8.3.3.3 Asia Pacific End of Production Cells Testing Market by Country
8.3.3.4 Asia Pacific Others Market by Country
8.3.4 Asia Pacific Mycoplasma Testing Market by End User
8.3.4.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
8.3.4.2 Asia Pacific Contract Research Organizations Market by Country
8.3.4.3 Asia Pacific Academic Research Institutes Market by Country
8.3.4.4 Asia Pacific Cell Banks Market by Country
8.3.4.5 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Mycoplasma Testing Market by Country
8.3.5.1 China Mycoplasma Testing Market
8.3.5.1.1 China Mycoplasma Testing Market by Product & Service
8.3.5.1.2 China Mycoplasma Testing Market by Technology
8.3.5.1.3 China Mycoplasma Testing Market by Application
8.3.5.1.4 China Mycoplasma Testing Market by End User
8.3.5.2 Japan Mycoplasma Testing Market
8.3.5.2.1 Japan Mycoplasma Testing Market by Product & Service
8.3.5.2.2 Japan Mycoplasma Testing Market by Technology
8.3.5.2.3 Japan Mycoplasma Testing Market by Application
8.3.5.2.4 Japan Mycoplasma Testing Market by End User
8.3.5.3 India Mycoplasma Testing Market
8.3.5.3.1 India Mycoplasma Testing Market by Product & Service
8.3.5.3.2 India Mycoplasma Testing Market by Technology
8.3.5.3.3 India Mycoplasma Testing Market by Application
8.3.5.3.4 India Mycoplasma Testing Market by End User
8.3.5.4 South Korea Mycoplasma Testing Market
8.3.5.4.1 South Korea Mycoplasma Testing Market by Product & Service
8.3.5.4.2 South Korea Mycoplasma Testing Market by Technology
8.3.5.4.3 South Korea Mycoplasma Testing Market by Application
8.3.5.4.4 South Korea Mycoplasma Testing Market by End User
8.3.5.5 Singapore Mycoplasma Testing Market
8.3.5.5.1 Singapore Mycoplasma Testing Market by Product & Service
8.3.5.5.2 Singapore Mycoplasma Testing Market by Technology
8.3.5.5.3 Singapore Mycoplasma Testing Market by Application
8.3.5.5.4 Singapore Mycoplasma Testing Market by End User
8.3.5.6 Malaysia Mycoplasma Testing Market
8.3.5.6.1 Malaysia Mycoplasma Testing Market by Product & Service
8.3.5.6.2 Malaysia Mycoplasma Testing Market by Technology
8.3.5.6.3 Malaysia Mycoplasma Testing Market by Application
8.3.5.6.4 Malaysia Mycoplasma Testing Market by End User
8.3.5.7 Rest of Asia Pacific Mycoplasma Testing Market
8.3.5.7.1 Rest of Asia Pacific Mycoplasma Testing Market by Product & Service
8.3.5.7.2 Rest of Asia Pacific Mycoplasma Testing Market by Technology
8.3.5.7.3 Rest of Asia Pacific Mycoplasma Testing Market by Application
8.3.5.7.4 Rest of Asia Pacific Mycoplasma Testing Market by End User
8.4 LAMEA Mycoplasma Testing Market
8.4.1 LAMEA Mycoplasma Testing Market by Product & Service
8.4.1.1 LAMEA Kits & Reagents Market by Country
8.4.1.2 LAMEA Instruments Market by Country
8.4.1.3 LAMEA Services Market by Country
8.4.2 LAMEA Mycoplasma Testing Market by Technology
8.4.2.1 LAMEA PCR Market by Country
8.4.2.2 LAMEA ELISA Market by Country
8.4.2.3 LAMEA Microbial Culture Techniques Market by Country
8.4.2.4 LAMEA Enzymatic Methods Market by Country
8.4.3 LAMEA Mycoplasma Testing Market by Application
8.4.3.1 LAMEA Cell Line Testing Market by Country
8.4.3.2 LAMEA Virus Testing Market by Country
8.4.3.3 LAMEA End of Production Cells Testing Market by Country
8.4.3.4 LAMEA Others Market by Country
8.4.4 LAMEA Mycoplasma Testing Market by End User
8.4.4.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
8.4.4.2 LAMEA Contract Research Organizations Market by Country
8.4.4.3 LAMEA Academic Research Institutes Market by Country
8.4.4.4 LAMEA Cell Banks Market by Country
8.4.4.5 LAMEA Others Market by Country
8.4.5 LAMEA Mycoplasma Testing Market by Country
8.4.5.1 Brazil Mycoplasma Testing Market
8.4.5.1.1 Brazil Mycoplasma Testing Market by Product & Service
8.4.5.1.2 Brazil Mycoplasma Testing Market by Technology
8.4.5.1.3 Brazil Mycoplasma Testing Market by Application
8.4.5.1.4 Brazil Mycoplasma Testing Market by End User
8.4.5.2 Argentina Mycoplasma Testing Market
8.4.5.2.1 Argentina Mycoplasma Testing Market by Product & Service
8.4.5.2.2 Argentina Mycoplasma Testing Market by Technology
8.4.5.2.3 Argentina Mycoplasma Testing Market by Application
8.4.5.2.4 Argentina Mycoplasma Testing Market by End User
8.4.5.3 UAE Mycoplasma Testing Market
8.4.5.3.1 UAE Mycoplasma Testing Market by Product & Service
8.4.5.3.2 UAE Mycoplasma Testing Market by Technology
8.4.5.3.3 UAE Mycoplasma Testing Market by Application
8.4.5.3.4 UAE Mycoplasma Testing Market by End User
8.4.5.4 Saudi Arabia Mycoplasma Testing Market
8.4.5.4.1 Saudi Arabia Mycoplasma Testing Market by Product & Service
8.4.5.4.2 Saudi Arabia Mycoplasma Testing Market by Technology
8.4.5.4.3 Saudi Arabia Mycoplasma Testing Market by Application
8.4.5.4.4 Saudi Arabia Mycoplasma Testing Market by End User
8.4.5.5 South Africa Mycoplasma Testing Market
8.4.5.5.1 South Africa Mycoplasma Testing Market by Product & Service
8.4.5.5.2 South Africa Mycoplasma Testing Market by Technology
8.4.5.5.3 South Africa Mycoplasma Testing Market by Application
8.4.5.5.4 South Africa Mycoplasma Testing Market by End User
8.4.5.6 Nigeria Mycoplasma Testing Market
8.4.5.6.1 Nigeria Mycoplasma Testing Market by Product & Service
8.4.5.6.2 Nigeria Mycoplasma Testing Market by Technology
8.4.5.6.3 Nigeria Mycoplasma Testing Market by Application
8.4.5.6.4 Nigeria Mycoplasma Testing Market by End User
8.4.5.7 Rest of LAMEA Mycoplasma Testing Market
8.4.5.7.1 Rest of LAMEA Mycoplasma Testing Market by Product & Service
8.4.5.7.2 Rest of LAMEA Mycoplasma Testing Market by Technology
8.4.5.7.3 Rest of LAMEA Mycoplasma Testing Market by Application
8.4.5.7.4 Rest of LAMEA Mycoplasma Testing Market by End User
Chapter 9. Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 Eurofins Scientific SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Recent strategies and developments:
9.3.4.1 Product Launches and Product Expansions:
9.3.4.2 Acquisition and Mergers:
9.3.5 SWOT Analysis
9.4 Lonza Group Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 InvivoGen SAS
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Asahi Kasei Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Norgen Biotek Corp.
9.9.1 Company Overview
9.10. PromoCell GmbH
9.10.1 Company Overview
9.10.2 SWOT Analysis
Chapter 10. Winning Imperatives for Mycoplasma Testing Market

Companies Mentioned

  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific SE
  • Lonza Group Ltd.
  • Bio-Rad Laboratories, Inc.
  • InvivoGen SAS
  • Asahi Kasei Corporation
  • F. Hoffmann-La Roche Ltd.
  • Norgen Biotek Corp.
  • PromoCell GmbH

Methodology

Loading
LOADING...